 Fulcrum Therapeutics, Inc. NASDAQ:FULC Q1 2022 Earnings Conference Call May 9, 2022 8:00 AM ET Company Participants Naomi Aoki - SVP, Corporate Communications IR Bryan Stuart - President CEO Judy Dunn - President, RD Esther Rajavelu - CFO Chris Morabito - CMO Paul Bruno - Executive Director, Corporate Development Conference Call Participants Judah Frommer - Credit Suisse Dae Gon Ha - Stifel Ted Tenthoff - Piper Sandler Joseph Schwartz - SVB Matt Biegler - Oppenheimer Operator Good morning and welcome to Fulcrum Therapeutics First Quarter 2022 Conference Call. Currently all participants are in a listen-only mode. 